Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR7C2 Inhibitors

OR7C2 is a protein that could play a significant role in cellular processes. The expression of proteins like OR7C2 is tightly regulated within the cell, where various signaling pathways and transcriptional mechanisms maintain the delicate balance of protein synthesis. Disruptions in the expression of such proteins may have cascading effects on cellular function, and thus, understanding the molecules that can inhibit gene expression is a critical area of research. Chemical compounds have the potential to interact with biomolecules and cellular structures, leading to changes in the expression levels of specific proteins. The inhibition of protein expression can occur at various stages of gene expression, from the unwinding of DNA to the post-transcriptional modification of mRNA. Some compounds might bind directly to DNA, blocking transcription factors or interfering with RNA polymerase binding and function. Others may interact with epigenetic markers, altering the histone code and thus affecting the chromatin state and gene accessibility. Furthermore, inhibitors can also affect the stability and translation of mRNA, providing multiple checkpoints at which protein expression can be downregulated. Among the array of chemicals that could inhibit the expression of OR7C2, several have been identified based on their known biochemical interactions. For instance, Trichostatin A, a histone deacetylase inhibitor, can lead to a more open chromatin state, potentially reducing transcriptional activity at gene loci such as that of OR7C2. Mitomycin C, through its DNA crosslinking action, could prevent the transcriptional machinery from accessing the OR7C2 gene, thus leading to decreased expression. Chloroquine, by accumulating in lysosomes and affecting autophagic processes, might alter cellular stress responses and thereby reduce the levels of certain proteins. Additionally, compounds like 5-Azacytidine and SN-38 target DNA methylation and topoisomerase I, respectively, both of which are crucial for the transcription and subsequent expression of proteins. By understanding the action of these inhibitors at the molecular level, researchers can elucidate the pathways that control gene expression, shedding light on the intricate web of interactions that govern cellular function.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A may downregulate OR7C2 by inhibiting histone deacetylase, leading to a more open chromatin structure and less transcriptional activity at the OR7C2 gene locus.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

By inhibiting DNA methyltransferase, 5-Azacytidine could cause the demethylation of the OR7C2 gene promoter, potentially resulting in the silencing of its expression.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D binds specifically to the DNA at the transcription initiation complex, potentially leading to a cessation of OR7C2 transcription by physically blocking the elongation process.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin may indirectly lead to the downregulation of OR7C2 expression by inhibiting mTOR, thus reducing the general transcriptional machinery available for the OR7C2 gene.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$66.00
$101.00
$143.00
85
(5)

Mitomycin C forms crosslinks within DNA strands. This crosslinking can lead to a decrease in OR7C2 expression by preventing the transcriptional enzymes from accessing the gene.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Chloroquine can concentrate in lysosomes, leading to reduced degradation of autophagic vesicles, which could decrease the expression of OR7C2 by altering cellular stress responses.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$66.00
$325.00
$587.00
$1018.00
28
(1)

Retinoic Acid could reduce the expression of OR7C2 by binding retinoic acid receptors that repress the transcription of genes during differentiation and development processes.

Tamoxifen

10540-29-1sc-208414
2.5 g
$272.00
18
(2)

Tamoxifen may decrease OR7C2 expression by competitively binding to estrogen receptor sites, thereby blocking estrogen-mediated transcriptional activation of the gene.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY 294002, by inhibiting PI3K, may downregulate OR7C2 through attenuation of the AKT signaling pathway, which is crucial for cell survival and gene expression.

SP600125

129-56-6sc-200635
sc-200635A
10 mg
50 mg
$40.00
$150.00
257
(3)

SP600125 inhibits the activity of JNK, potentially leading to the downregulation of OR7C2 expression by disrupting the JNK signaling cascade that can induce gene expression.